Determining the association between systematic lupus erythematosus and the occurrence of primary biliary cirrhosis: a systematic review and meta-analysis

医学 原发性胆汁性肝硬化 相伴的 荟萃分析 内科学 梅德林 肝硬化 红斑狼疮 系统回顾 胃肠病学 免疫学 抗体 政治学 法学
作者
Natchaya Polpichai,Sakditad Saowapa,Shu‐Yen Chan,Phuuwadith Wattanachayakul,Pojsakorn Danpanichkul,Panisara Fangsaard,Angkawipa Trongtorsak
出处
期刊:European Journal of Gastroenterology & Hepatology [Lippincott Williams & Wilkins]
卷期号:36 (9): 1126-1132
标识
DOI:10.1097/meg.0000000000002791
摘要

Background Autoimmune diseases often coexist; however, the concomitant occurrence of systemic lupus erythematosus (SLE) and primary biliary cirrhosis (PBC) is rare. Therefore, this study aims to provide a comprehensive summary of evidence regarding the co-occurrence of SLE and PBC. Methods PubMed, Web of Science, ScienceDirect , and Google Scholar databases were systematically and comprehensively searched for records published up to February 2024. Full-text articles that aligned with the study’s aim were included, while those published in languages other than English and those designed as case reports, reviews, conference abstracts, or editorials were excluded. Statistical analyses were performed using Comprehensive Meta-Analysis software, and methodological quality was assessed using the Newcastle–Ottawa Scale. Results Only 14 studies that met the inclusion criteria with 3944 PBC and 9414 SLE patients were included for review and analysis. Pooled data analysis revealed that approximately 1.1% of SLE patients have concomitant PBC (range: 0.02–7.5%), while around 2.7% of PBC patients concurrently have SLE (range: 1.3–7.5%). Furthermore, qualitative data analysis indicated that the prevalence of PBC in SLE patients presenting with hepatic dysfunction or abnormal liver enzymes ranges from 2 to 7.5%. Conclusion Although the concomitant occurrence of SLE and PBC is rare, the small proportion of patients where these diseases coexist warrants close monitoring by clinicians. This underscores the importance of surveillance to prevent their co-occurrence.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
今后的应助被辛勤泥猴桃采纳,获得10
刚刚
1秒前
bff完成签到,获得积分10
2秒前
迷途书童发布了新的文献求助10
2秒前
Akim的应助被wct采纳,获得10
2秒前
XuHT完成签到,获得积分10
2秒前
xxx完成签到 ,获得积分10
3秒前
八十发布了新的文献求助10
3秒前
烨无殇完成签到,获得积分10
3秒前
华仔的应助被典雅翅膀采纳,获得10
3秒前
3秒前
hh完成签到 ,获得积分10
4秒前
4秒前
苹果芷雪发布了新的文献求助10
4秒前
彩色蚂蚁发布了新的文献求助10
4秒前
Atheist的应助被BGW采纳,获得10
5秒前
爆米花的应助被webel采纳,获得10
5秒前
光亮凉面完成签到,获得积分10
6秒前
6秒前
科研通AI2S的应助被科研通管家采纳,获得10
6秒前
天天快乐的应助被科研通管家采纳,获得10
6秒前
6秒前
科目三的应助被科研通管家采纳,获得10
6秒前
CodeCraft的应助被zhangerya采纳,获得10
6秒前
大猫发布了新的文献求助20
6秒前
风格的应助被科研通管家采纳,获得20
6秒前
充电宝的应助被科研通管家采纳,获得10
7秒前
Hello的应助被科研通管家采纳,获得10
7秒前
CORAL完成签到,获得积分10
7秒前
null的应助被科研通管家采纳,获得10
7秒前
tttt完成签到 ,获得积分10
7秒前
7秒前
风格的应助被科研通管家采纳,获得30
7秒前
上官若男的应助被陈泓宇采纳,获得10
7秒前
SciGPT的应助被qian采纳,获得10
7秒前
Ava的应助被科研通管家采纳,获得10
7秒前
null的应助被科研通管家采纳,获得10
7秒前
8秒前
江奖姜酱发布了新的文献求助10
9秒前
陈cxz完成签到 ,获得积分10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160632
求助须知:如何正确求助?哪些是违规求助? 9555512
关于积分的说明 21728801
捐赠科研通 7750444
什么是DOI,文献DOI怎么找? 3427429
关于科研通互助平台的介绍 2552456
邀请新用户注册赠送积分活动 2471817